Company ProfilePremium

Beximco Pharmaceuticals Ltd

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Beximco Pharmaceuticals Ltd - Healthcare showcase

Year Founded & Workforce

1980

3,800 Employees

Industry

Healthcare

Services

Respiratory
B

Beximco Pharmaceuticals Ltd Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Beximco Pharmaceuticals Ltd Overview

Company Headquarters: Dhaka, Bangladesh

Founded: 1980

Workforce: ~3,800+

Company Working: Beximco Pharmaceuticals Ltd (Beximco) is an emerging generic drug company. The company has manufacturing facilities accredited by the regulatory authorities of Australia, European Union, Canada, and Brazil, among others. Beximco is consistently building upon its portfolio and currently producing more than 500 products encompassing broad therapeutic categories, and the company has created strong differentiation by offering a range of high-tech, specialized products that are difficult to imitate. Beximco exports its medicines to more than 50 countries around the world.

Strategy

Beximco’s focus is on providing affordable medications and building presence in many emerging and developed markets around the world. The company is also focused on improving its core capabilities to address the unmet medical needs of patients.

Company Snapshot

$237.5M

Revenue

3,800

Employees

1980

Founded

Dhaka, Bangladesh

Headquarters

SWOT Analysis

Strengths

  • Strong product portfolio
  • 55% revenue from exporting pharmaceutical products

Weaknesses

  • Inconsistent in supplying products

Opportunities

  • Entering other by launching products

Threats

  • Changing exchange rates

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • Beximco Pharmaceuticals Ltd
    • Respiratory

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales fell from USD 237.5 Mn in 2016 to USD 210 Mn in 2018.
Beximco Pharmaceuticals Ltd — By Business Segment
Series (USD Mn)201620172018
Sales237.5183.9210
R&D Expenditure3.12.82.6

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.